Portfolio Companies

Founded in 2000, Giant Biogene is a leader in the bioactive ingredient-based professional skin treatment product industry in China. Years of R&D on bioactive ingredients and integrated business model enable the company to achieve the technological and market leadership positions in the industry. The company designs, develops and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods.

Giant Biogene utilize proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house.

On November 4, 2022, Giant Biogene was officially listed on the Main Board of the Hong Kong Stock Exchange (HKEX) under the stock code 2367.HK.